Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -20.60%51.79B | 32.13%238.93B | 11.42%60.12B | 99.40%65.22B | -26.41%180.84B | 49.18B | -17.27%53.96B | -30.12%45B | -41.63%32.71B | 0.12%245.72B |
| Cost of revenue | -17.57%29.57B | 29.58%137.19B | 9.43%35.25B | 94.58%35.87B | -26.94%105.87B | 30.12B | -17.09%32.22B | -31.96%25.11B | -44.04%18.44B | 4.74%144.92B |
| Gross profit | -24.30%22.22B | 35.72%101.74B | 14.37%24.87B | 105.63%29.35B | -25.63%74.97B | 19.06B | -17.52%21.74B | -27.64%19.89B | -38.18%14.28B | -5.85%100.81B |
| Operating expense | 8.95%12.5B | 14.03%50.42B | 13.93%12.59B | 11.58%11.48B | -1.16%44.22B | 12.38B | 2.03%11.05B | -5.19%10.51B | 1.77%10.29B | 22.86%44.74B |
| Selling and administrative expenses | 10.81%12.79B | 13.75%50.52B | 10.80%12.54B | 12.38%11.54B | 2.22%44.41B | --12.24B | 3.06%11.32B | -3.99%10.58B | 1.55%10.27B | 22.69%43.45B |
| -General and administrative expense | 10.81%12.79B | 13.75%50.52B | 10.80%12.54B | 12.38%11.54B | 2.22%44.41B | --12.24B | 3.06%11.32B | -3.99%10.58B | 1.55%10.27B | 22.69%43.45B |
| Other operating expenses | -33.33%18M | -48.05%253M | 315.79%79M | -40.00%27M | -68.82%487M | --390M | -53.66%19M | -62.50%33M | 95.65%45M | 26.48%1.56B |
| Total other operating income | 230.43%304M | -48.75%348M | -90.18%28M | 206.67%92M | 151.48%679M | --254M | 49.21%285M | 266.67%110M | 0.00%30M | 16.88%270M |
| Operating profit | -45.65%9.72B | 66.92%51.32B | 14.83%12.27B | 348.07%17.88B | -45.16%30.75B | 6.68B | -31.16%10.69B | -42.81%9.38B | -69.27%3.99B | -20.65%56.06B |
| Net non-operating interest income (expenses) | -201.53%-395M | 46.26%-531M | -2,049.06%-1.03B | 50.19%-131M | -484.62%-988M | -540M | -62.14%53M | -1,181.82%-238M | -216.87%-263M | 87.82%-169M |
| Non-operating interest income | -45.60%68M | 167.85%908M | -359.79%-730M | 52.44%125M | -62.71%339M | ---134M | -38.78%281M | -63.33%110M | -46.05%82M | 316.97%909M |
| Non-operating interest expense | 80.86%463M | 8.44%1.44B | 32.89%303M | -25.80%256M | 23.10%1.33B | --406M | -28.53%228M | 25.18%348M | 46.81%345M | -32.88%1.08B |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -47.47%9.32B | 70.68%50.79B | 4.65%11.24B | 376.17%17.75B | -46.76%29.76B | 6.14B | -31.44%10.74B | -44.34%9.15B | -71.11%3.73B | -19.30%55.9B |
| Income tax | -42.72%2.55B | 100.26%14.79B | 14.46%3.24B | 314.65%4.45B | -52.64%7.38B | 496M | -38.56%2.83B | -41.80%2.99B | -67.48%1.07B | -13.03%15.59B |
| Net income | -49.06%6.78B | 60.92%36B | 1.14%8B | 401.02%13.3B | -44.49%22.37B | 5.65B | -28.47%7.91B | -45.49%6.16B | -72.36%2.66B | -21.49%40.31B |
| Net income continuous operations | -49.06%6.78B | 60.92%36B | 1.14%8B | 401.02%13.3B | -44.49%22.37B | --5.65B | -28.47%7.91B | -45.49%6.16B | -72.36%2.66B | -21.49%40.31B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -49.06%6.78B | 60.92%36B | 1.14%8B | 401.02%13.3B | -44.49%22.37B | 5.65B | -28.47%7.91B | -45.49%6.16B | -72.36%2.66B | -21.49%40.31B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -49.06%6.78B | 60.92%36B | 1.14%8B | 401.02%13.3B | -44.49%22.37B | 5.65B | -28.47%7.91B | -45.49%6.16B | -72.36%2.66B | -21.49%40.31B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -48.77%29.08 | 59.68%154.6 | 1.14%34.65 | 392.57%56.76 | -44.65%96.82 | 24.28 | -28.66%34.26 | -45.49%26.727 | -72.36%11.5232 | -21.49%174.9336 |
| Diluted earnings per share | -47.89%28.97 | 62.80%152.54 | 3.25%34.27 | 398.97%55.59 | -44.50%93.7 | 23.59 | -28.37%33.19 | -45.38%25.8403 | -72.36%11.141 | -21.58%168.8366 |
| Dividend per share | 0 | 236.36%37 | 0 | 0 | 11 | 11 | ||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |